Cargando…
Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536906/ https://www.ncbi.nlm.nih.gov/pubmed/35880379 http://dx.doi.org/10.14802/jmd.22021 |
_version_ | 1784803077029625856 |
---|---|
author | Nishikawa, Noriko Hatano, Taku Kamiyama, Daiki Haginiwa-Hasegawa, Haruna Oyama, Genko Hattori, Nobutaka |
author_facet | Nishikawa, Noriko Hatano, Taku Kamiyama, Daiki Haginiwa-Hasegawa, Haruna Oyama, Genko Hattori, Nobutaka |
author_sort | Nishikawa, Noriko |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9536906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Korean Movement Disorder Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-95369062022-10-24 Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose Nishikawa, Noriko Hatano, Taku Kamiyama, Daiki Haginiwa-Hasegawa, Haruna Oyama, Genko Hattori, Nobutaka J Mov Disord Letter to the Editor The Korean Movement Disorder Society 2022-09 2022-07-26 /pmc/articles/PMC9536906/ /pubmed/35880379 http://dx.doi.org/10.14802/jmd.22021 Text en Copyright © 2022 The Korean Movement Disorder Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Nishikawa, Noriko Hatano, Taku Kamiyama, Daiki Haginiwa-Hasegawa, Haruna Oyama, Genko Hattori, Nobutaka Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title | Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title_full | Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title_fullStr | Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title_full_unstemmed | Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title_short | Continuous 24-h Levodopa-Carbidopa Intestinal Gel Infusion After a Levodopa Holiday Suppressed Refractory Dyskinesia Despite Increasing Levodopa Dose |
title_sort | continuous 24-h levodopa-carbidopa intestinal gel infusion after a levodopa holiday suppressed refractory dyskinesia despite increasing levodopa dose |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536906/ https://www.ncbi.nlm.nih.gov/pubmed/35880379 http://dx.doi.org/10.14802/jmd.22021 |
work_keys_str_mv | AT nishikawanoriko continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose AT hatanotaku continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose AT kamiyamadaiki continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose AT haginiwahasegawaharuna continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose AT oyamagenko continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose AT hattorinobutaka continuous24hlevodopacarbidopaintestinalgelinfusionafteralevodopaholidaysuppressedrefractorydyskinesiadespiteincreasinglevodopadose |